Special Issue "Epidemiology and Treatment of Atopic Eczema"
Deadline for manuscript submissions: closed (30 November 2014)
Dr. Sebastien Barbarot
Dermatology Department, Pediatric Dermatology Unit, CHU Hotel Dieu, 44093 Nantes, France
Interests: pediatric dermatology; patient reported outcoumes in eczema trials; adherence to topical treatments; topical steroid phobia in eczema; education programs in eczema; neurofibromatosis type 1; hemangioma; congenital nevi
Prof. Dr. Kim Thomas
Division of Rheumatology, Orthopaedics and Dermatology, School of Medicine, University of Nottingham, Room A103, King’s Meadow Campus, Lenton Lane, Nottingham, NG7 2NR, UK
Website | E-Mail
Fax: +44 115 84 68618
Interests: the design and conduct of dermatology clinical trials for the treatment and prevention of skin disease; clinical trial methodologies of interest include outcomes research, efficient trial designs, consensus methodologies and patient and public involvement in research
Eczema (also known as atopic eczema or atopic dermatitis), is estimated to affect one in five school children, and is increasing worldwide. It is a condition that impacts on both the patient and their family, and has a large impact on healthcare resource use.
For such a common condition, it is perhaps surprising that there are still so many unanswered questions about its causes, possible strategies for its prevention, and the best and safest ways of treating the disease.
This Special Issue compiles articles that reflect current best practice from around the world in the management of eczema, along with new insights into the causes, mechanisms and strategies for prevention.
Prof. Dr. Kim Thomas
Dr. Sébastien Barbarot
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- atopic dermatitis
- atopic eczema
- skin disease